|

Diabetes Clinical Trials in Indianapolis, IN

38 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 YearsN/A<1 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)Phase 3<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesPhase 2<1 mi
Rare and Atypical Diabetes Network—<1 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesN/A<1 mi
Type 1 Diabetes Extension Study—<1 mi
Fenofibrate for Prevention of DR WorseningPhase 3<1 mi
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesPhase 1/2<1 mi
Monitoring Exhaled Breath to Noninvasively Detect Glycemic EventsN/A<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPhase 3<1 mi
Biomarker of Diabetic Retinopathy—<1 mi
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin ActionPhase 2<1 mi
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot TrialN/A<1 mi
Bionic Pancreas in CFRDPhase 3<1 mi
Mechanisms Underlying Impaired Diabetic Wound Healing—<1 mi
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW PopulationsN/A<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/2<1 mi
Intensive Glycemic Targets in Overweight and Obese Women With Gestational DiabetesN/A<1 mi
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)Phase 2<1 mi
T1D Pregnancy & Me—<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics—<1 mi
Denosumab for Type 1 DiabetesPhase 1/2<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms—<1 mi
TrialNet Pathway to Prevention of T1D—<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesPhase 3<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesPhase 2<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Phase 3<1 mi
Registry for Stage 2 Type 1 Diabetes—<1 mi
CGM Dynamic Index for Predicting Prediabetes in Cystic FibrosisN/A<1 mi
Drug Interaction Potential of Pro-Inflammatory Conditions—<1 mi
To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.N/A<1 mi
Enhancing Shared Decision-making to Guide Care for People With Dementia and DiabetesN/A<1 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)Phase 3<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/A<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 313 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatidePhase 214 mi
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)—15 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseasePhase 315 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.